Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rare Diseases Clinical Research Network Advancing Research and Treatment for Frontotemporal Lobar Degeneration [ARTFL]: Research Projects 1 & 2

NCT02365922 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT02365922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02365922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rare Diseases Clinical Research Network Advancing Research and Treatment for Frontotemporal Lobar Degeneration [ARTFL]: Research Projects 1 & 2
Lead sponsor
University of California, San Francisco
Phase
Observational
Overall status
Completed
Start date
September 30, 2014
Completion date
September 30, 2020
Enrollment
1,489 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

amyotrophic lateral sclerosis (als), behavioral variant frontotemporal dementia (bvftd), corticobasal degeneration (cbd), corticobasal syndrome (cbs), frontotemporal dementia (ftd), ftd with amyotrophic lateral sclerosis (ftd/als), ftld, nonfluent variant primary progressive aphasia (nfvppa), oligosymptomatic psp (opsp), ppa syndrome, progressive supranuclear palsy (psp), semantic variant primary progressive aphasia (svppa)